Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment

This publication has 13 references indexed in Scilit:

• Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
  British Journal of Haematology, 1997
• Serum levels of tumour necrosis factor-α predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome
  Clinical and Laboratory Haematology, 1997
• A sequential erythropoietin and GM-CSF schedule offers clinical benefits in the treatment of anaemia in myelodysplastic syndromes
  Leukemia Research, 1996
• Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy
  Blood, 1996
• Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studies
  British Journal of Haematology, 1995
• Efficacy of Recombinant Human Erythropoietin in the Treatment of Refractory Anemias Without Excess of Blasts in Myelodysplastic Syndromes
  Leukemia & Lymphoma, 1994
• Treatment of myelodysplastic syndromes with recombinant human erythropoietin
  European Journal of Haematology, 1991
• Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]
  Blood, 1991
• The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin
  British Journal of Haematology, 1991
• Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia
  The International Journal of Cell Cloning, 1990